© 2024 grapl ltd.
The European Centralised Procedure (CP)
Course Summary
The Centralised Procedure (CP) is one of three routes available to applicants to gain multinational marketing authorisation within the European Economic Area (EEA) on the basis of a single application. In the CP, one successful application leads to a marketing authorisation being issued by the European Commission that applies throughout the EEA. The CP is mandatory for certain types of products.
This module describes the various players in the procedure, the sequence and duration of the stages involved, and the requirements on content, format and timing of submissions.
Purchasing Information
When you have completed your course order, Zenosis will finalise the setup of your course materials and contact you on the email address that you provide in your order. You can expect this process to be completed within one business day (using the UK business calendar) of completing your payment.
It is therefore essential that you use your real email address for your order, or indicate in the purchase notes the email address to be used for the course set-up, and check that any messages from Zenosis or grapl are not lost in your junk or spam folder.
You will have access to the course module(s) for a period of 180 days after your purchase is complete.
Detailed Course Information
Learning Objectives
• Provide an overview of the CP process.
• Identify which products may/must use the CP.
• For products for which the CP is optional, outline the advantages and disadvantages of the CP compared with other routes to marketing authorisation.
• Describe requirements on content, format and timing of submissions.
• Specify the sequence and duration of the stages of the CP and the responsibilities of the participants.
• Describe the role of the European Medicines Agency and its relevant competent committee.
• Outline fast-track provisions.
• Describe the appeals procedure.
Who will benefit from this course
This module is primarily aimed at regulatory affairs professionals dealing with marketing authorisation applications and related submissions for regulatory approval in Europe. More generally, it will also be of interest to all those involved in the development and registration of medicinal products.
Module Outline
• Module overview
– Provides an overview of the content of the module and outlines related Zenosis modules.
• An introduction to the Centralised Procedure
– This session provides background information. It specifies the types of product for which the CP is mandatory and those for which it is optional. It discusses the types of Marketing Authorisation Application, and characteristics of the application procedure.
• The Centralised Procedure process
– This session takes you through the entire process from pre-submission to what happens after an Opinion has been received.
• Assessment
– Multiple-choice mastery assessment.
Roles
Regulatory
CPD Points
1.5
Region
Level
Introductory/Intermediate
Course Study Time
Approx 1.5 hours
Europe